Cohort Study of Intrauterine Diseases

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention (observational study): No intervention (observational study)

Study summary

"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases."

Eligibility

Primary outcome measure(s)

• The recurrence of endometrial polyps or endometrial hyperplasia. — Follow up every three months for one year after hysteroscopic surgery
  To evaluate the presence of disease progression and recurrence through imaging results.

Trial sites (1)

Other trials for the same condition